GnRH agonists versus antagonists: Reducing cardiovascular risks in men with advanced prostate cancer

    Activity: Other › Types of Award - Other distinction

    Description

    Donation of £169,500.00
    Period30 Sept 2016 → 29 Sept 2019
    Held atFerring Pharmaceuticals